Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
4.000
+0.290 (7.82%)
At close: Nov 4, 2024, 4:00 PM
3.913
-0.087 (-2.16%)
Pre-market: Nov 5, 2024, 9:23 AM EST
Cabaletta Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Net Income | -89.98 | -67.68 | -52.98 | -46.29 | -33.34 | -16.94 | |
Depreciation & Amortization | 1.51 | 1.43 | 1.18 | 0.73 | 0.35 | 0.1 | |
Loss (Gain) From Sale of Investments | -2.21 | -1.22 | -0.22 | 0.06 | 0.12 | - | |
Stock-Based Compensation | 14.86 | 11.34 | 6.9 | 5.8 | 4.39 | 2.3 | |
Other Operating Activities | 4.94 | 2.48 | 3.04 | - | - | - | |
Change in Accounts Payable | 2.14 | 1.68 | -0.03 | 0.98 | 0.56 | 0.25 | |
Change in Other Net Operating Assets | -5.1 | -1.57 | -4.27 | 4.61 | 1.15 | -1.75 | |
Operating Cash Flow | -73.83 | -53.55 | -46.38 | -34.11 | -26.77 | -16.05 | |
Capital Expenditures | -1.83 | -0.69 | -2.45 | -1.17 | -0.64 | -0.69 | |
Investment in Securities | 25.82 | -21.76 | -24.76 | 7.17 | -7.35 | - | |
Investing Cash Flow | 23.99 | -22.45 | -27.22 | 6 | -7.98 | -0.69 | |
Issuance of Common Stock | 100.38 | 187.63 | 32.98 | 48.9 | 0.17 | 71.22 | |
Other Financing Activities | - | - | - | - | -0.19 | -1.29 | |
Financing Cash Flow | 100.38 | 187.63 | 32.98 | 48.9 | -0.02 | 119.93 | |
Net Cash Flow | 50.54 | 111.63 | -40.62 | 20.79 | -34.78 | 103.19 | |
Free Cash Flow | -75.66 | -54.24 | -48.83 | -35.28 | -27.41 | -16.74 | |
Free Cash Flow Per Share | -1.61 | -1.32 | -1.66 | -1.37 | -1.18 | -3.06 | |
Levered Free Cash Flow | -45.62 | -30.41 | -29.25 | -17.82 | -15.53 | -11.13 | |
Unlevered Free Cash Flow | -45.62 | -30.41 | -29.25 | -17.82 | -15.53 | -11.13 | |
Change in Net Working Capital | -2.41 | -4.17 | 1.04 | -5.75 | -1.51 | 1.17 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.